Day One Biopharmaceutical... (DAWN)
NASDAQ: DAWN
· Real-Time Price · USD
6.83
0.02 (0.29%)
At close: Aug 19, 2025, 3:59 PM
6.81
-0.29%
After-hours: Aug 19, 2025, 05:27 PM EDT
Day One Biopharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 35.62M | 33.36M | 124.97M | 422.76M | 239.62M | 270.39M | 230.78M | 241.18M | 189.21M | 49.27M | 85.26M | 120.86M | 388.88M | 262.73M | 284.31M | 297.16M | 310M | 154.87M |
Short-Term Investments | 417.48M | 439.66M | 406.75M | 135.62M | 122.25M | 47.55M | 135.56M | 164.36M | 253.67M | 268.91M | 257.01M | 253.48M | 5.99M | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 183K | 215K | 121K | 117K | 117K | 167K | 214K | 7.99M | 259K | 487K | 469K | 449K | 484K | 165K | 169K | 137K | 126K | 1.69M |
Receivables | 19.67M | 18.05M | 13.88M | 8.7M | 9.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 6.54M | 3.56M | 3.32M | 2.73M | 151K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 15.11M | 3.97M | 4.37M | 3.45M | 7.61M | 4.58M | 2.35M | 2.23M | 781K | 782K | 1.01M | 946K | 839K | 398K | 1.01M | 173K | 174K | n/a |
Total Current Assets | 494.43M | 508.65M | 562.33M | 581M | 383.16M | 326.03M | 375.27M | 405.54M | 449.78M | 322.39M | 347.87M | 380.51M | 402.5M | 267.37M | 289.37M | 303.31M | 316.02M | 158.75M |
Property-Plant & Equipment | 4.82M | 5.08M | 4.71M | 3.48M | 360K | 444K | 560K | 655K | 713K | 688K | 719K | 899K | 1.06M | 246K | 284K | 335K | 386K | 435K |
Goodwill & Intangibles | 19.61M | 20.41M | 15.63M | 16.22M | 16.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 24.61M | 25.7M | 20.46M | 19.81M | 17.28M | 611K | 774K | 8.64M | 972K | 1.18M | 1.19M | 1.35M | 1.54M | 411K | 453K | 472K | 512K | 2.13M |
Total Assets | 519.04M | 534.36M | 582.79M | 600.81M | 400.44M | 326.64M | 376.05M | 414.18M | 450.76M | 323.56M | 349.06M | 381.86M | 404.05M | 267.78M | 289.82M | 303.78M | 316.54M | 160.88M |
Account Payables | 5.09M | 2.54M | 3.26M | 3.02M | 6.44M | 4.78M | 2.58M | 3.39M | 4.57M | 4.66M | 260K | 3.97M | 439K | 701K | 1.74M | 683K | 348K | 686K |
Deferred Revenue | 1.85M | 1.64M | 1.55M | 1.46M | n/a | n/a | 25.48M | 20.24M | 19.33M | n/a | n/a | n/a | 11.77M | n/a | 6.61M | 4.98M | 4.02M | 2.17M |
Short-Term Debt | 153K | n/a | 10K | n/a | 190K | n/a | 408K | 437K | 428K | 417K | n/a | 462K | 427K | 171K | n/a | 202K | 201K | n/a |
Other Current Liabilities | 1.98M | 3.06M | 12.15M | 23.69M | 57.94M | 874K | 633K | -28K | -242K | 14.54M | 179K | 8.33M | 8.72M | 5.49M | 104K | -17K | 508K | 1.48M |
Total Current Liabilities | 51.22M | 47.88M | 73.45M | 39.74M | 93.71M | 29.84M | 29.51M | 24.48M | 24.51M | 22.85M | 16.61M | 18.27M | 12.8M | 8.18M | 8.66M | 6.05M | 4.66M | 3.07M |
Long-Term Debt | 2.85M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 761K | 761K | 761K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 221.72M |
Total Long-Term Liabilities | 6.98M | 6.96M | 6.59M | 5.6M | n/a | n/a | n/a | 77K | 190K | 300K | 408K | 514K | 617K | 872K | 16K | 65K | 112K | 221.88M |
Total Liabilities | 58.2M | 54.84M | 80.04M | 45.34M | 93.71M | 29.84M | 29.51M | 818.25M | 24.7M | 23.15M | 17.02M | 18.79M | 13.42M | 8.18M | 8.67M | 6.11M | 4.77M | 224.95M |
Total Debt | 3M | 2.92M | 2.6M | 2.62M | 190K | 300K | 408K | 514K | 618K | 717K | 813K | 976K | 1.04M | 171K | 220K | 267K | 313K | 358K |
Common Stock | 10K | 10K | 10K | 10K | 9K | 9K | 9K | 9K | 9K | 7K | 7K | 7K | 7K | 6K | 6K | 6K | 6K | 2M |
Retained Earnings | -620.4M | -590.08M | -554.08M | -488.37M | -525.4M | -521M | -458.58M | -404.07M | -357.92M | -312.06M | -269.67M | -229.56M | -191.76M | -155.23M | -127.49M | -105.55M | -86.31M | -72.02M |
Comprehensive Income | -92K | -52K | 84K | -6K | -22K | -5K | 9K | -7K | -9K | 67K | -71K | -392K | -3K | n/a | n/a | -303.78M | n/a | n/a |
Shareholders Equity | 460.83M | 479.51M | 502.75M | 555.46M | 306.73M | 296.81M | 346.54M | -404.07M | 426.05M | -312.06M | 332.04M | 363.08M | 390.63M | 259.6M | -127.49M | 297.67M | 311.76M | -68.85M |
Total Investments | 417.48M | 439.66M | 406.75M | 135.62M | 122.25M | 47.55M | 135.56M | 164.36M | 253.67M | 268.91M | 257.01M | 253.48M | 5.99M | n/a | n/a | n/a | n/a | n/a |